HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
MONDAY, April 3, 2017 (HealthDay News) -- Adequate sleep isn't a luxury; it's essential. And for men, it might even mean the difference between life and death, a preliminary study suggests.
Researchers found that men younger than 65 who slept just three to five hours a night were 55 percent more likely to develop fatal prostate cancer than those who got the recommended seven hours of shuteye nightly.
And, six hours of sleep a night was linked to a 29 percent higher risk of prostate cancer death compared to seven hours.
"If confirmed in other studies, these findings would contribute to evidence suggesting the importance of obtaining adequate sleep for better health," said lead study author Susan Gapstur, vice president of epidemiology at the American Cancer Society.
However, more research is needed to better understand the biologic mechanisms, said Gapstur. For now, she considers the study "intriguing" but not substantive enough to cause sleep-deprived males any alarm.
Still, the findings contribute to evidence that the body's natural sleep/wake cycle -- circadian rhythms -- might play a role in prostate cancer development, Gapstur said.
The study results stem from an analysis of long-term data on more than 823,000 men in the United States. The findings were scheduled for presentation Monday at the annual meeting of the American Association for Cancer Research, in Washington, D.C.
Lack of sleep can inhibit production of melatonin, a hormone that affects sleep cycles. Low melatonin production can lead to an increase in genetic mutations, greater oxidative damage, reduced DNA repair and a weakened immune system, Gapstur said in an association news release.
Lack of sleep may also contribute to the disruption of genes involved in tumor suppression, she added.
It's not clear why the link between limited sleep and higher death risk from prostate cancer wasn't seen in men 65 and older. But, Gapstur suggested that the natural decline in nocturnal melatonin levels with age might possibly reduce the relative impact of lack of sleep.
The National Sleep Foundation recommends adults get at least seven hours of sleep a night.
Research presented at meetings should be considered preliminary until published in a peer-reviewed medical journal.
The U.S. National Cancer Institute has more on prostate cancer.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at firstname.lastname@example.org with any questions.
Updated on May 29, 2022